Genesis Healthcare Company Profile (NYSE:GEN)

About Genesis Healthcare (NYSE:GEN)

Genesis Healthcare logoGenesis Healthcare, Inc. is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. As of December 31, 2016, the Company offered inpatient services through its network of 499 skilled nursing and assisted/senior living facilities across 34 states, consisting of 473 skilled nursing facilities and 26 stand-alone assisted/senior living facilities. Its services focus primarily on the medical and physical issues facing elderly patients and are provided by its skilled nursing companies, assisted or senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Residential & Long Term Care
  • Sub-Industry: N/A
  • Symbol: NYSE:GEN
  • CUSIP: N/A
  • Web:
  • Market Cap: $97.09 million
  • Outstanding Shares: 94,721,000
Average Prices:
  • 50 Day Moving Avg: $1.15
  • 200 Day Moving Avg: $1.87
  • 52 Week Range: $0.91 - $4.75
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.15
  • P/E Growth: -0.07
Sales & Book Value:
  • Annual Revenue: $5.45 billion
  • Price / Sales: 0.02
  • Book Value: ($6.52) per share
  • Price / Book: -0.16
  • EBIDTA: $450.3 million
  • Net Margins: -2.05%
  • Return on Assets: -2.71%
  • Debt-to-Equity Ratio: -5.49%
  • Current Ratio: 1.26%
  • Quick Ratio: 1.26%
  • Average Volume: 655,161 shs.
  • Beta: 1.18
  • Short Ratio: 1.63

Frequently Asked Questions for Genesis Healthcare (NYSE:GEN)

What is Genesis Healthcare's stock symbol?

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

How were Genesis Healthcare's earnings last quarter?

Genesis Healthcare, Inc. (NYSE:GEN) released its earnings results on Thursday, November, 3rd. The company reported ($0.23) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.40) by $0.17. The company earned $1.42 billion during the quarter, compared to analysts' expectations of $1.39 billion. The company's revenue for the quarter was up .2% on a year-over-year basis. During the same quarter last year, the business posted $0.07 earnings per share. View Genesis Healthcare's Earnings History.

Where is Genesis Healthcare's stock going? Where will Genesis Healthcare's stock price be in 2017?

2 brokerages have issued 1-year price targets for Genesis Healthcare's stock. Their predictions range from $2.00 to $2.00. On average, they expect Genesis Healthcare's share price to reach $2.00 in the next twelve months. View Analyst Ratings for Genesis Healthcare.

Who are some of Genesis Healthcare's key competitors?

Who are Genesis Healthcare's key executives?

Genesis Healthcare's management team includes the folowing people:

  • Robert H. Fish, Chairman of the Board
  • Paul David Bach, President, Executive Vice President
  • George V. Hager Jr., Chief Executive Officer, Director
  • Thomas DiVittorio, Chief Financial Officer, Treasurer, Assistant Secretary
  • Daniel Allen Hirschfeld, President - Genesis Rehab Services
  • Stephen Saville, President of Career Staff Unlimited
  • Jeanne Phillips, Chief Human Resource Officer
  • David C. Almquist, Executive Vice President, President West Division
  • Richard P. Blinn, Executive Vice President, President Northeast Division
  • Raymond L. Thivierge, Executive Vice President - West Division

Who owns Genesis Healthcare stock?

Genesis Healthcare's stock is owned by many different of retail and institutional investors. Top institutional investors include FISHMAN STEVEN E. (64.80%), ONEX CORP (14.20%), ONEX CORP (13.20%), HighTower Advisors LLC (4.00%), First Washington CORP (2.12%) and JPMorgan Chase & Co. (1.54%). Company insiders that own Genesis Healthcare stock include Daniel Allen Hirschfeld, George V Hager Jr, James V Mckeon, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis Healthcare.

Who sold Genesis Healthcare stock? Who is selling Genesis Healthcare stock?

Genesis Healthcare's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Dimensional Fund Advisors LP, TIAA CREF Investment Management LLC, Citadel Advisors LLC, Acadian Asset Management LLC, OxFORD Asset Management LLP, Bank of New York Mellon Corp and California Public Employees Retirement System. Company insiders that have sold Genesis Healthcare stock in the last year include Daniel Allen Hirschfeld, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare.

Who bought Genesis Healthcare stock? Who is buying Genesis Healthcare stock?

Genesis Healthcare's stock was purchased by a variety of institutional investors in the last quarter, including First Washington CORP, JPMorgan Chase & Co., Virtu KCG Holdings LLC, SG Americas Securities LLC, BSW Wealth Partners, Great West Life Assurance Co. Can, Northern Trust Corp and State Street Corp. Company insiders that have bought Genesis Healthcare stock in the last two years include James V Mckeon and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare.

How do I buy Genesis Healthcare stock?

Shares of Genesis Healthcare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Genesis Healthcare's stock price today?

One share of Genesis Healthcare stock can currently be purchased for approximately $1.03.

MarketBeat Community Rating for Genesis Healthcare (NYSE GEN)
Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  149 (Vote Underperform)
Total Votes:  227
MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Genesis Healthcare (NYSE:GEN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $2.00 (95.12% upside)

Analysts' Ratings History for Genesis Healthcare (NYSE:GEN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/13/2017Royal Bank Of CanadaReiterated RatingHold$2.00LowView Rating Details
7/5/2017Cantor FitzgeraldInitiated CoverageOverweightHighView Rating Details
9/19/2016Bank of America CorporationSet Price TargetSell$1.80N/AView Rating Details
5/11/2016StephensDowngradeOverweight -> HoldN/AView Rating Details
1/26/2016Susquehanna Bancshares IncLower Price TargetNeutral$5.50 -> $2.75N/AView Rating Details
(Data available from 9/22/2015 forward)


Earnings History for Genesis Healthcare (NYSE:GEN)
Earnings by Quarter for Genesis Healthcare (NYSE:GEN)
Earnings History by Quarter for Genesis Healthcare (NYSE GEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 17($0.25)($0.50)$1.40 billion$1.39 billionViewListenView Earnings Details
11/3/2016Q3($0.40)($0.23)$1.39 billion$1.42 billionViewN/AView Earnings Details
8/4/2016Q2$0.01($0.26)$1.40 billion$1.44 billionViewN/AView Earnings Details
5/9/2016Q1$0.03($0.01)$1.43 billion$1.47 billionViewN/AView Earnings Details
11/5/2015Q315$0.07$0.07$1.42 billion$1.42 billionViewN/AView Earnings Details
8/6/2015Q215$0.09$0.14$1.43 billion$1.41 billionViewN/AView Earnings Details
2/19/2015Q412$0.14$0.14$209.50 million$1.19 billionViewN/AView Earnings Details
11/9/2012Q312$0.03$0.18$935.06 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Genesis Healthcare (NYSE:GEN)
Current Year EPS Consensus Estimate: $-1.450 EPS
Next Year EPS Consensus Estimate: $-0.890 EPS


Dividend History for Genesis Healthcare (NYSE:GEN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Genesis Healthcare (NYSE:GEN)
Insider Ownership Percentage: 57.59%
Institutional Ownership Percentage: 14.90%
Insider Trades by Quarter for Genesis Healthcare (NYSE:GEN)
Institutional Ownership by Quarter for Genesis Healthcare (NYSE:GEN)
Insider Trades by Quarter for Genesis Healthcare (NYSE:GEN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2017Joanne Susan ReifsnyderEVPSell5,269$1.73$9,115.37View SEC Filing  
6/14/2017Michael Scott ShermanSVPSell3,903$1.73$6,752.19View SEC Filing  
6/14/2017Paul David BachCOOSell6,100$1.73$10,553.00View SEC Filing  
6/14/2017Stephen Scott YoungVPSell3,799$1.73$6,572.27View SEC Filing  
6/14/2017Thomas DivittorioCFOSell6,341$1.73$10,969.93View SEC Filing  
6/7/2017Daniel Allen HirschfeldCOOSell2,895$1.61$4,660.95View SEC Filing  
6/7/2017Joanne Susan ReifsnyderEVPSell2,383$1.61$3,836.63View SEC Filing  
6/7/2017Michael Scott ShermanSVPSell1,824$1.61$2,936.64View SEC Filing  
6/7/2017Stephen Scott YoungVPSell1,541$1.61$2,481.01View SEC Filing  
6/7/2017Thomas DivittorioCFOSell2,900$1.61$4,669.00View SEC Filing  
8/29/2016Stephen Scott YoungVPSell10,000$2.38$23,800.00View SEC Filing  
6/8/2016Daniel Allen HirschfeldCOOSell3,009$1.72$5,175.48View SEC Filing  
6/8/2016George V Hager JrCEOSell6,031$1.72$10,373.32View SEC Filing  
6/8/2016Joanne Susan ReifsnyderEVPSell2,207$1.72$3,796.04View SEC Filing  
6/8/2016Michael Scott ShermanSVPSell1,919$1.72$3,300.68View SEC Filing  
6/8/2016Stephen Scott YoungVPSell1,621$1.72$2,788.12View SEC Filing  
6/8/2016Thomas DivittorioCFOSell3,051$1.72$5,247.72View SEC Filing  
11/12/2015James V MckeonDirectorBuy10,000$4.15$41,500.00View SEC Filing  
11/11/2015Thomas DivittorioCFOBuy20,000$4.34$86,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Genesis Healthcare (NYSE:GEN)
Latest Headlines for Genesis Healthcare (NYSE:GEN)
DateHeadline logoBRIEF-Sabra enters into agreements to acquire 49 pct equity interest in senior housing joint ventures managed by Enlivant - September 19 at 6:58 PM logoCloudMine Honored as Health Care Innovator by Philadelphia Business Journal - September 18 at 11:37 PM logoGenesis Rehab Services Honored by Philadelphia Business Journal as a 2017 Health Care Innovator - September 18 at 6:35 PM logoGenesis Healthcare, Inc. (GEN) Receives Hold Rating from Royal Bank Of Canada - September 13 at 9:44 PM logoGenesis HealthCare Opens 11th PowerBack Rehabilitation Location - September 12 at 7:48 PM logoHealth Care Heroes award winner: Genesis Medical Associates Inc. - September 12 at 12:32 AM logoGenesis HealthCare Applauds Employee Response to Hurricane Harvey - September 8 at 7:28 PM logoSabra Health Care REIT (SBRA) Offers Update on CCP Portfolio Repositioning, FY17 & FY18 Outlook - September 7 at 7:09 PM logoSabra Provides Update on Care Capital Properties (“CCP”) Portfolio ... - September 7 at 7:09 PM logoFinancial Analysis: Genesis Healthcare (GEN) & Five Star Senior Living (FVE) - August 29 at 8:40 AM logoTroubled Eagle Crest nursing home to close, resulting in 72 layoffs - August 28 at 6:40 PM logoFujifilm Secures DIN-PACS IV Contract from U.S. Department of Defense - August 25 at 5:47 AM logoGenesis Healthcare, Pioneer in Genetic Health Testing, Announces 1.4 Bil. Yen New Share Issue to Rakuten - PR Newswire (press release) - August 23 at 7:42 AM logoGenesis Healthcare (GEN) and Five Star Senior Living (FVE) Financial Analysis - August 15 at 10:58 AM logoCoinMD Mines Genesis Block at Public Event - August 12 at 12:26 AM logoGenesis to continue divestment strategy into 2018 - August 10 at 11:26 PM logoEdited Transcript of GEN earnings conference call or presentation 9-Aug-17 12:30pm GMT - August 10 at 12:11 AM logoInvestor Network: Genesis Healthcare Inc Class A to Host Earnings Call - August 9 at 7:09 PM logoSee what the IHS Markit Score report has to say about Genesis Healthcare Inc. - August 9 at 7:09 PM logoEARNINGS SUMMARY: Details of Genesis Healthcare Inc. Q2 Earnings Report - August 9 at 4:42 AM logoGenesis HealthCare Reports Second Quarter 2017 Results - August 8 at 11:41 PM logoGenesis Healthcare reports 2Q loss - August 8 at 11:41 PM logoGenesis Healthcare (SKH) vs. Genesis Healthcare (GEN) Head to Head Comparison - August 8 at 6:26 PM logoGenesis Healthcare (SKH) vs. Genesis Healthcare (GEN) Head-To-Head Contrast - August 6 at 12:30 AM logoCritical Survey: Civitas Solutions (CIVI) versus Genesis Healthcare (NYSE:GEN) - August 2 at 7:58 AM logoHead-To-Head Review: Genesis Healthcare (NYSE:GEN) versus Brookdale Senior Living (BKD) - July 28 at 8:10 AM logoCritical Comparison: Omnicare (OCR) vs. Genesis Healthcare (GEN) - July 25 at 8:30 AM logoEminence Capital Plans to Vote Against Sabra's Care Capital Deal - Bloomberg - July 24 at 9:12 AM logoOmega Healthcare: What Is The Worst That Could Happen? - July 20 at 12:44 AM logoEight Genesis HealthCare Centers Receive Silver National Quality Award - July 10 at 6:57 PM logoHead-To-Head Contrast: Genesis Healthcare (GEN) and Brookdale Senior Living (BKD) - July 9 at 8:23 AM logoBenzinga's Top Upgrades, Downgrades For July 6, 2017 - Benzinga - July 7 at 2:13 AM logoGenesis Healthcare, Inc. (NYSE:GEN) Coverage Initiated by Analysts at Cantor Fitzgerald - July 5 at 9:20 PM logoSix Genesis HealthCare Centers Receive Bronze National Quality Award - June 28 at 6:40 PM logoGenesis HealthCare Finalizes Agreement With U.S. Department of Justice - June 16 at 6:06 PM logo$53.6M settlement: Genesis Healthcare reaches deal to resolve federal lawsuits - June 16 at 6:06 PM logoThe Latest: Genesis HealthCare pleased to resolve probes - June 16 at 6:06 PM logoGenesis HealthCare to pay $53.6M to settle US probes - June 16 at 6:06 PM logoInsider Selling: Genesis Healthcare, Inc. (GEN) COO Sells 6,100 Shares of Stock - June 15 at 5:02 PM logoInsider Selling: Genesis Healthcare, Inc. (GEN) CFO Sells 6,341 Shares of Stock - June 15 at 5:02 PM logoForm 8-K Genesis Healthcare, Inc. For: Jun 07 - - June 12 at 6:14 PM logoForm 4 Genesis Healthcare, Inc. For: Jun 07 Filed by: Hirschfeld Daniel Allen - June 9 at 10:51 PM logoForm 4 Genesis Healthcare, Inc. For: Jun 07 Filed by: BLOEM JAMES H - - June 8 at 11:24 PM logoForm 4 Genesis Healthcare, Inc. For: Jun 07 Filed by: Reis David A - June 8 at 6:24 PM logoGenesis Healthcare Inc (GEN) Upgraded by ValuEngine to Sell - June 8 at 4:08 PM logoGenesis Healthcare (GEN) vs. Capital Senior Living (CSU) Financial Analysis - June 7 at 4:42 PM logoSt. Clair Hospital to create accountable care organization - June 7 at 10:59 AM logoETFs with exposure to Genesis Healthcare, Inc. : June 6, 2017 - June 6 at 5:49 PM logoMonday Sector Laggards: Hospital & Medical Practitioners, General Contractors & Builders - June 5 at 5:31 PM logoETFs with exposure to Genesis Healthcare, Inc. : May 26, 2017 - May 26 at 6:04 PM



Genesis Healthcare (GEN) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by Staff